Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder

Launched by ASSIUT UNIVERSITY · Oct 24, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how effective cognitive behavioral therapy (CBT) can be in treating people who have a problem with methamphetamine use. CBT is a type of talk therapy that helps individuals understand and change their thoughts and behaviors related to their drug use. The trial aims to see if this approach can really help those struggling with methamphetamine addiction.

To be eligible for the study, participants need to be males aged between 15 and 49 years who have used methamphetamine and meet certain criteria for addiction. They should have completed more than nine years of education and have a positive urine test for methamphetamine. However, individuals with other serious mental health issues, like bipolar disorder or schizophrenia, or those involved in legal cases that prevent them from committing to a 12-week treatment program, cannot participate. If chosen for the trial, participants can expect to engage in therapy sessions over a 12-week period focused on overcoming their addiction. This trial is not yet recruiting, so there is still time to learn more if you or someone you know might be interested.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • patients who meet the criteria for methamphetamine use disorder according to Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM 5) (10)
• • aged of 15-49 years' old
• • more than 9 year of education
• • urine drug screening positive for methamphetamine
• Exclusion Criteria:
• • other Axis I disorder of DSM-V criteria such as bipolar disorder, schizophrenia, depression
• • Had a legal case pending resulting in inability to commit to 12 weeks of treatment.
• • Refusal to participate
• • poly drug dependence.